# NIH Reporter #1K99AG103301-01

Therapeutic development to target tau using immunotherapy and CRISPR-based approaches

**Recipient:** University of North Carolina at Chapel Hill

**Award Amount:** $138,701.00
**Ceiling:** $138,701.00

**Awarded:** September 11, 2026

**Identifier:** 1K99AG103301-01

NIH grant awarded for research on tau targeting in Alzheimer's disease using immunotherapy and CRISPR, managed by UNC Chapel Hill.

### Description

This NIH grant opportunity supports research on tau protein targeting in Alzheimer's disease using immunotherapy and CRISPR-based approaches. The project is managed by the University of North Carolina at Chapel Hill and funded by the National Institute on Aging (NIA), part of the NIH.

[View original record](https://reporter.nih.gov/search/0C83gI3MXki4-tEhFD4UKQ/project-details/11437587)